全文获取类型
收费全文 | 861篇 |
免费 | 1篇 |
专业分类
化学工业 | 2篇 |
金属工艺 | 1篇 |
机械仪表 | 1篇 |
轻工业 | 2篇 |
一般工业技术 | 1篇 |
冶金工业 | 853篇 |
自动化技术 | 2篇 |
出版年
2022年 | 1篇 |
2020年 | 1篇 |
2015年 | 1篇 |
2012年 | 1篇 |
2011年 | 1篇 |
2006年 | 1篇 |
2003年 | 2篇 |
1999年 | 23篇 |
1998年 | 243篇 |
1997年 | 130篇 |
1996年 | 99篇 |
1995年 | 52篇 |
1994年 | 57篇 |
1993年 | 50篇 |
1992年 | 8篇 |
1991年 | 7篇 |
1990年 | 12篇 |
1989年 | 16篇 |
1988年 | 13篇 |
1987年 | 15篇 |
1986年 | 16篇 |
1985年 | 9篇 |
1983年 | 1篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 8篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 19篇 |
1976年 | 63篇 |
1975年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有862条查询结果,搜索用时 9 毫秒
41.
J Holst B Lindblad D Bergqvist O Nordfang PB Ostergaard JG Petersen G Nielsen U Hedner 《Canadian Metallurgical Quarterly》1994,71(2):214-219
The aim was to investigate whether a truncated recombinant Tissue Factor Pathway Inhibitor (TFPI1-161), which lacked the third Kunitz-type domain and the basic c-terminal region, had an antithrombotic effect comparable to LMWH in a randomised double-dummy study. The experimental thrombosis was induced in jugular veins, in a total of 40 rabbits by a combination of destruction of the endothelium and restricted blood flow. Group 1: placebo, gr 2: LMWH 60 anti-FXa IU/kg, gr 3-5: 0.1, 1.0 and 10.0 mg/kg TFPI1-161. TFPI1-161 reduced the thrombus weights in all treated groups, significantly in doses of 1.0 and 10.0 mg/kg compared to placebo. The frequency of thrombosis and occlusive thrombosis were also significantly reduced in those doses. The antithrombotic properties of TFPI1-161 (1.0-10.0 mg/kg) measured as thrombus weight, frequency of thrombosis and frequency of occlusive thrombosis was equivalent to the anti-thrombotic properties of LMWH. In the anti-FXa, APTT and PT-assays TFPI1-161 displayed a dose dependent increase of activity. Recombinant-TFPI1-161 did not influence the anti-FIIa-assay. No haemorrhagic side effects were noted. 相似文献
42.
43.
JC Clouse M Rogers RC Reba JL Littlefield PB Schneider M Pollycove 《Canadian Metallurgical Quarterly》1998,39(7):11N-13N, 27N, 30N
44.
45.
46.
L Pulkkinen PB Cserhalmi-Friedman M Tang MC Ryan J Uitto AM Christiano 《Canadian Metallurgical Quarterly》1998,78(9):1067-1076
47.
Teleoperation is frequently performed with misalignments between operator or camera viewing direction and controller orientation. Examples of this occur in endoscopic surgery and in teleoperation with multiple camera views. The objective of this study was to find a method to automatically compensate for those misalignments so that human operators performing tasks under such scenarios could achieve levels of performance comparable to aligned conditions without additional training requirements. In this paper we report on a set of experiments conducted to test a method developed for that purpose. Participants were asked to track a randomly moving target on a computer display using a cursor controlled with a joystick. Performance was recorded under various visual-motor misalignments with and without automated compensation. Results indicated significant improvements in operator performance through use of automatic compensation only under certain types of misalignment. Actual or potential applications of this research include teleoperation and endoscopic surgery. 相似文献
48.
49.
50.
SJ Lee KM Kuntz MM Horowitz PB McGlave JM Goldman KA Sobocinski J Hegland C Kollman SK Parsons MC Weinstein JC Weeks JH Antin 《Canadian Metallurgical Quarterly》1997,127(12):1080-1088
BACKGROUND: Chronic myelogenous leukemia (CML) is an indolent but ultimately fatal disease. Because the natural history of CML varies and quality of life with CML may be excellent until shortly before death, deciding whether and when to pursue unrelated donor bone marrow transplantation is often difficult. OBJECTIVE: To compare early transplantation, delayed transplantation, and no transplantation for patients with chronic-phase CML on the basis of discounted, quality-adjusted life expectancy. DESIGN: A markov model comparing different strategies was constructed. This model considers patient age, quality of life, risk aversion, and the competing risks for CML progression and transplant toxicity. SETTING: Therapeutic decision at the time of diagnosis of CML. PATIENTS: The base case is a 35-year-old patient with intermediate-prognosis CML. Younger and older patients with better and worse prognoses are also evaluated. INTERVENTION: Early transplantation, delayed transplantation, and no transplantation. MEASUREMENTS: Quality-adjusted, discounted life expectancy. RESULTS: For patients with newly diagnosed CML, transplantation within the first year provides the greatest quality-adjusted expected survival, although this benefit decreases with increasing patient age. For a 35-year-old patient with intermediate-prognosis CML, transplantation within the first year results in 53 more discounted, quality-adjusted years of life expectancy than does no transplantation. This finding is robust even with varying baseline assumptions. CONCLUSIONS: These results support the use of early unrelated donor bone marrow transplantation for most patients with CML. 相似文献